Abstract
Background Severe falciparum malaria is difficult to diagnose accurately in children in high transmission settings. Platelet counts and plasma concentrations of P. falciparum histidinerich protein-2 (Pf HRP2) are potential biomarkers to increase diagnostic accuracy.
Methods We fitted Bayesian latent class models to platelet counts and Pf HRP2 concentrations in 2,649 patients enrolled in four studies of severe illness in three countries (Bangladesh, Kenya, and Uganda). We estimated receiver operating characteristic curves and compared parasite densities, haematocrits, total white blood cell counts, blood culture positivity rates, and haemoglobin S genotypes (HbAS and HbSS) across the subgroups defined by the probabilistic models.
Findings The platelet count and the plasma Pf HRP2 concentration have substantial diagnostic value in severe malaria. In severely ill patients with clinical features consistent with severe malaria, a combined platelet count ≤ 150,000 per µL and a plasma Pf HRP2 concentration ≥ 1,000 ng/mL had an estimated sensitivity of 74% and specificity of 93% in identifying ‘true’ severe falciparum malaria. We estimate one third of African children enrolled in the two clinical studies of severe malaria had another cause of severe illness. Under the model, patients with severe malaria had higher parasite densities, lower haematocrits, lower rates of invasive bacterial disease, and a lower prevalence of both HbAS and HbSS than children misdiagnosed. Mortality in ‘true’ severe malaria was consistent across the African sites at ∼ 10%.
Interpretation Studies of severe falciparum malaria in African children would be improved by including only patients with platelet counts ≤ 150,000 per µL and plasma Pf HRP2 concentrations ≥ 1,000 ng/mL.
Funding Wellcome
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was done as part of SMAART (Severe Malaria Africa A consortium for Research and Trials) funded by a Wellcome Collaborative Award in Science grant (209265/Z/17/Z) held in part by KM, NPJD and AMD. JAW is a Sir Henry Dale Fellow jointly funded by the Wellcome Trust and the Royal Society (223253/Z/21/Z). TNW and NJW are senior and principal research fellows respectively funded by the Wellcome Trust (202800/Z/16/Z and 093956/Z/10/C, respectively). ECG acknowledges funding from a core grant to the MRC CTU at UCL from the MRC (MCUU12023/26). CCJ and ROO acknowledge grant R01 NS055349 from the National Institutes for Neurologic Disorders and Stroke. The FEAST trial was supported by a grant (G0801439) from the Medical Research Council, United Kingdom provided through the (MRC) DFID concordat. KM and ECG were supported by this grant.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This analysis of anonymised patient data already collected in previous studies does not require ethics approval as per guidelines from the Oxford University Tropical Medicine Ethics Committee (OXTREC).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
A minimal clinical dataset is available online via the following github repository: https://github.com/jwatowatson/SevereMalariaDiagnosis.